Clinical Trial Update: Comparison of 30% Metformin and 2% Nicotinamide Lotion With Kligman Formula in the Treatment of Melasma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing a 30% metformin and 2% nicotinamide lotion with Kligman formula for melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Metformin 30% (metformin)
• Nicotinamide 2% (nicotinamide)

Snippet

Sponsor: Ishtiaq Ahmed | Conditions: Melasma | Phase 2 | Status: COMPLETED